Does Wegovy Cause Constipation?
For the broader cluster context, see the semaglutide side effects and safety hub. This guide is part of the Compounded Semaglutide Side Effects and Safety cluster, itself part of the compounded semaglutide pillar guide.
Author: HealthRX.com Editorial Team
Compounded semaglutide lacks FDA approval. While this post provides educational information for patients, it's not a substitute for talking with your doctor. Your prescriber should make all decisions about whether semaglutide is right for you, what dose to use, and how to monitor your treatment.
Yes, constipation is a common and expected side effect of semaglutide, whether taken as Wegovy, Ozempic, or a compounded preparation. It is not a rare reaction. It shows up because of how the drug works, and in most cases it responds well to a few specific changes rather than requiring a dose change or stopping the medication.
What the Trial Data Shows
In the STEP-1 trial, the pivotal study that supported Wegovy's approval for weight management, gastrointestinal symptoms were the most commonly reported adverse effects in participants taking semaglutide. Nausea was the single most frequent complaint, and constipation was reported in roughly one in four participants on semaglutide, compared with a substantially smaller share on placebo (STEP-1, Wilding et al., 2021). These figures come from the published trial report and should be checked against the source directly during medical review before being restated elsewhere as exact percentages.
Most gastrointestinal side effects, including constipation, followed a similar pattern in the trial: they were more likely to appear around a dose increase and tended to improve over the following weeks rather than persisting indefinitely.
Wegovy's FDA label includes a boxed warning about thyroid C-cell tumors that appeared in animal studies, though this risk hasn't been confirmed in people (Wegovy prescribing information, FDA). Due to this warning, doctors usually ask about personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia type 2 before prescribing. The label also flags pancreatitis as a potential risk that warrants prompt medical evaluation if symptoms develop, which is distinct from the common side effect of constipation.
Why Semaglutide Slows Your Gut
Semaglutide works partly by slowing gastric emptying and intestinal transit, which is part of how it produces the fullness signal that reduces appetite (Wegovy prescribing information, FDA). The digestive system does not separate this intended effect from its side effect: slower transit is slower transit, whether it is helping you feel full or making stool harder to pass.
A second, behavioral factor often compounds this. When appetite drops, people tend to eat and drink less overall, including at meals where they might otherwise take in fluid alongside food. Lower fluid intake combined with less food volume moving through the colon reduces the mechanical stimulus that normally prompts a bowel movement. This is a reasonable clinical explanation based on how the drug and reduced intake interact, rather than a finding pulled from a specific trial.
What Actually Helps
These are the first-line approaches most prescribers recommend, and they resolve most cases without a dose change:
Hydration. Many clinicians managing GLP-1 patients suggest increasing water intake noticeably above baseline, since people eating less often drink less without realizing it. Ask your prescriber what target makes sense for you rather than following a generic number.
Fiber. Soluble fiber from food, oats, chia seeds, cooked vegetables, and beans if tolerated, tends to be gentler than jumping straight to a supplement. Increase gradually, since adding a large amount of fiber too quickly can itself cause bloating.
Smaller, lower-fat meals around a dose change. In the first one to two weeks after starting or increasing a dose, lighter meals reduce overall gastrointestinal load. This is a transitional strategy, not a permanent diet.
Osmotic laxatives, such as polyethylene glycol (MiraLAX), are a routine and appropriate short-term tool when hydration and fiber alone are not enough. Ask your prescriber before adding one regularly, and be cautious with stimulant laxatives, which work differently and are not typically a first choice.
Constipation Decision Framework
Use this as a starting point for what to do, not a substitute for talking to your prescriber about your specific situation.
| Situation | Likely explanation | What to try first | Call your prescriber |
|---|---|---|---|
| No bowel movement for 1 to 3 days, no pain, started right after a dose increase | Expected transit slowing from the new dose | Increase water intake, add soluble fiber at meals, a short walk after eating can help | Not yet, but keep track of it |
| No bowel movement for 4 to 6 days despite more water and fiber | Diet and hydration changes alone are not enough | Ask about a short course of an osmotic laxative | If there is no improvement within 1 to 2 days of starting one |
| Constipation lasting more than a week regardless of what you have tried | May need clinical evaluation rather than more self-management | Stop trying to manage it alone | Yes, call now |
| Constipation plus severe abdominal pain, vomiting, or bloating unlike your baseline | Could reflect something beyond routine constipation | Do not wait it out | Yes, call now or seek urgent care |
| Constipation plus fever, inability to pass gas, or a hard, distended abdomen | Possible bowel obstruction or other emergency | Do not take a laxative | Seek urgent or emergency care |
When to Call Your Prescriber
Beyond the constipation-specific thresholds above, contact your prescriber promptly for vomiting lasting more than a day, severe upper abdominal pain (especially if it radiates to the back, which can suggest pancreatitis), signs of dehydration, jaundice, persistent severe headache, or vision changes. Most people on semaglutide never approach this territory, but it is worth knowing the thresholds rather than guessing in the moment.
Does Side Effect Intensity Mean the Drug Is Working?
There is no reliable evidence that the severity of nausea, constipation, or other gastrointestinal side effects predicts how much weight someone will lose. This idea circulates often in patient communities, but it is not something the available trial data support. If your side effects are mild or manageable, that is not a sign the medication is failing to work.
Compounded Semaglutide: Same Molecule, Different Regulatory Path
The active ingredient in compounded semaglutide preparations is the same molecule found in Wegovy and Ozempic, so the mechanism behind constipation and the interventions described above apply the same way. Where compounded semaglutide differs is regulatory status: it is prepared by licensed 503A or 503B compounding pharmacies under a clinician's prescription, it is not FDA-approved, and it has not been independently studied in randomized trials at the scale of the branded products. That distinction affects oversight and quality assurance, not the underlying pharmacology of how the drug affects gut motility.
The STEP-4 Lesson About Duration
The STEP-4 trial randomized participants who had already lost weight on semaglutide to either continue the medication or switch to placebo, and found meaningful weight regain in the group that stopped, over roughly the following months, according to a randomized trial of continued versus discontinued semaglutide. The practical takeaway for constipation management is that if you expect to stay on this medication long-term, treating the hydration and fiber changes as permanent habits rather than a temporary workaround will serve you better than reverting once the initial adjustment period passes.
STEP-3 paired semaglutide with a structured intensive behavioral therapy program and found this combination outperformed semaglutide with standard counseling alone, according to a randomized trial of semaglutide paired with intensive behavioral therapy. Lifestyle support is additive to the medication, not optional for durable results.
Related Topics in This Cluster
- Ozempic and Nausea: Why It Happens and How to Reduce It
- Constipation on Semaglutide: A Practical Guide
- Nausea from Semaglutide: Mechanism, Prevention, Response
Adjacent Reading
Where This Fits
This article is part of the Compounded Semaglutide Side Effects and Safety cluster. For the regulatory pathway, the 503A and 503B compounding framework, and the broader clinical evidence base, the compounded semaglutide pillar guide is the primary reference on this site.
Frequently Asked Questions
Are the side effects of compounded semaglutide different from Wegovy or Ozempic?
The active ingredient is the same molecule, so the mechanism behind constipation and other gastrointestinal effects is the same. Compounded preparations are not FDA-approved and have not been independently studied in randomized trials at the same scale as the branded products.
When should constipation trigger a call to the prescriber?
If it persists beyond a week despite adequate hydration and fiber, or if it comes with severe pain, vomiting, or bloating unlike your baseline, contact your prescriber. Fever, inability to pass gas, or a hard and distended abdomen warrant urgent care rather than a routine call.
Do side effects predict how well the medication will work?
No. Available trial data do not show a reliable link between gastrointestinal side effect severity and the amount of weight lost.
Is it safe to use over-the-counter laxatives while on semaglutide?
Osmotic laxatives like polyethylene glycol are commonly used short-term under a prescriber's guidance. Stimulant laxatives work through a different mechanism and are generally worth discussing with your clinician first rather than using routinely.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP-1). https://pubmed.ncbi.nlm.nih.gov/33567185/
- Wegovy (semaglutide) prescribing information, FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/213051s012lbl.pdf
This article is intended as patient education and does not replace consultation with a licensed clinician. HealthRX.com is not a medical practice. Medications referenced here are dispensed by licensed pharmacies through independent clinician evaluations, and individual results vary.